The relationships between depression and life activities and well-being of multiple sclerosis patients

  • Rytis Leonavičius
  • Virginija Adomaitienė
  • Darius Leskauskas
Research Article


Multiple sclerosis (MS) is one of the most disabling neurodegenerative disorders. Depression is the most frequent psychiatric disorder accompanying MS. Although much attention is given to correlations between depression and MS clinical factors, analysis of correlations between depression and life activities (social, household, professional activities and family life) and the well-being of MS patients’ is insufficient. However, improvement of these functions could positively influence the outcomes of MS treatment. The aim of this study was to evaluate relationships between depression, life activities of MS patients, and their proposals how to improve the well-being. Materials and methods. The study lasted three years with 270 adult MS patients involved in it. ICD-10 criteria were used to diagnose depression. Original questionnaire was used to measure life activities and the well-being of the patients. Results. Prevalence of depression was 20.7% with no difference regarding the gender. Almost 84% of depressed respondents indicated, that MS disturbs their family life, 71.4% recommended to assign more attention to MS in general and 64.3% — to include more medications into reimbursement list. Conclusions. MS patients diagnosed with depression significantly more often than non-depressed indicate that MS disturbs their family life; recommend to assign more attention to MS in general and to include more medications into reimbursement list.


Multiple sclerosis Depression Life activities Well-being Proposals 


  1. [1]
    Pugliatti M., Sotgiu S., Rosati G., The worldwide prevalence of multiple sclerosis, Clin. Neurol. Neurosurg., 2002, 104(3), 182–191PubMedCrossRefGoogle Scholar
  2. [2]
    Pugliatti M., Rosati G., Carton H., Riise T., Drulovic J., Vecsei L., et al., The epidemiology of multiple sclerosis in Europe, Eur. J. Neurol., 2006, 13(7), 700–722PubMedCrossRefGoogle Scholar
  3. [3]
    Frohman E.M., Racke M.K., Raine C.S., Multiple sclerosis — the plaque and its pathogenesis, N. Engl. J. Med., 2006, 354(9), 942–955PubMedCrossRefGoogle Scholar
  4. [4]
    Bar-Or A., Immunology of multiple sclerosis, Neurol. Clin., 2005, 23, 149–175PubMedCrossRefGoogle Scholar
  5. [5]
    Janardhan V., Bakshi R., Quality of life in patients with multiple sclerosis: the impact of fatigue and depression, J. Neurol. Sci.., 2002, 205(1), 51–58PubMedCrossRefGoogle Scholar
  6. [6]
    Giannini M.J., Bergmark B., Kreshover S., Elias E., Plummer C., O’Keefe E., Understanding suicide and disability through three major disabling conditions: Intellectual disability, spinal cord injury, and multiple sclerosis, Disabil. Health J., 2010, 3(2), 74–78PubMedCrossRefGoogle Scholar
  7. [7]
    Fragoso Y.D., Frota E.R., Lopes J.S., Noal J.S., Giacomo M.C., Gomes S., et al., Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis, Clin. Neuropharmacol., 2010, 33(6), 312–316PubMedCrossRefGoogle Scholar
  8. [8]
    Patten S.B., Beck C.A., Williams J.V., Barbui C., Metz L.M., Major depression in multiple sclerosis: a population-based perspective, Neurology, 2003, 61(11), 1524–1527PubMedGoogle Scholar
  9. [9]
    Siegert R.J., Abernethy D.A., Depression in multiple sclerosis: a review, J. Neurol. Neurosurg. Psychiatry, 2005, 76(4), 469–475PubMedCrossRefGoogle Scholar
  10. [10]
    Chwastiak L., Ehde D.M., Gibbons L.E., Sullivan M., Bowen J.D., Kraft G.H., Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample, Am. J. Psychiatry, 2002, 159(11), 1862–1868PubMedCrossRefGoogle Scholar
  11. [11]
    Wynia K., Middel B., van Dijk J.P., De Keyser J.H., Reijneveld S.A., The impact of disabilities on quality of life in people with multiple sclerosis, Mult. Scler., 2008, 14, 972–980PubMedCrossRefGoogle Scholar
  12. [12]
    Putzki N., Fischer J., Gottwald K., Reifschneider G., Ries S., Siever A., et al., Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis, Eur. J. Neurol., 2009, 16, 713–720PubMedCrossRefGoogle Scholar
  13. [13]
    Hermann B.P., Vickrey B., Hays R.D., Cramer J., Devinsky O., Meador K., et al., A comparison of health-related quality of life in patients with epilepsy, diabetes, and multiple sclerosis, Epilepsy Res. 1996, 25(2), 113–118PubMedCrossRefGoogle Scholar
  14. [14]
    Hart S., Fonareva I., Merluzzi N., Mohr D.C., Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients, Quality of Life Res., 2005, 14(3), 695–703CrossRefGoogle Scholar
  15. [15]
    Sobocki P., Pugliatti M., Lauer K., Kobelt G., Estimation of the cost of MS in Europe: extrapolations from a multinational cost study, Mult. Scler., 2007, 13(8), 1054–1064PubMedCrossRefGoogle Scholar
  16. [16]
    Riazi A., Hobart J., Lamping D., Fitzpatrick R., Freeman J., Jenkinson C., at al., Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles, J. Neurol. Neurosurg. Psychiatry, 2003, June, 74(6), 710–714PubMedCrossRefGoogle Scholar
  17. [17]
    Kurtzke J.F., Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 1983, 33(11), 1444–1452PubMedGoogle Scholar
  18. [18]
    Moran P.J., Mohr D.C., The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis, J. Behav. Med., 2005, 28(1), 35–41PubMedCrossRefGoogle Scholar
  19. [19]
    Zung W.W.K., A self-rating depression scale, Arch. Gen. Psychiatry, 1965, 12, 63–70PubMedGoogle Scholar
  20. [20]
    Friedman S., Even C., Samuelian J.C., Guelfi J.D., Factor structure of the Hospital Anxiety and Depression (HAD) Scale, B. J. Psychiatry, 2002, 181(8), 165–166Google Scholar
  21. [21]
    The ICD-10 Classification of Mental and Behavioural Disorders, Diagnostic criteria for research, World Health Organization, Geneva, 1993Google Scholar
  22. [22]
    Arnett P.A., Randolph J.J., Longitudinal course of depression symptoms in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 2006, 77(5), 606–610PubMedCrossRefGoogle Scholar
  23. [23]
    Galeazzi G.M., Ferrari S., Giaroli G., Mackinnon A., Merelli E., Motti L., et al., Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy, Neurol. Sci., 2005, 26(4), 255–262PubMedCrossRefGoogle Scholar
  24. [24]
    McGuigan C., Hutchinson M., Unrecognized symptoms of depression in a community-based population with multiple sclerosis, J. Neurol., 2006, 253(2), 219–232PubMedCrossRefGoogle Scholar
  25. [25]
    Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al., The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R), JAMA, 2003, 289(23), 3095–3105PubMedCrossRefGoogle Scholar
  26. [26]
    Rihmer Z., Angst J., Mood disorders: epidemiology, In: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 8th ed. (1), Lippincott Williams & Wilkins, Philadelphia, 2005, 1575–1582Google Scholar
  27. [27]
    Piccinelli M., Wilkinson G., Gender differences in depression. Critical review, Br. J. Psychiatry, 2000, 177, 486–492PubMedCrossRefGoogle Scholar
  28. [28]
    Buchanan R.J., Wang S., Tai-Seale M., Ju H., Analyses of nursing home residents with multiple sclerosis and depression using the Minimum Data Set, Mult. Scler., 2003, March, 9(2), 171–188PubMedCrossRefGoogle Scholar
  29. [29]
    Chwastiak L.A., Ehde D.M., Psychiatric Issues in Multiple Sclerosis, Psychiatr. Clin. North. Am., 2007, 30(4), 803–817PubMedCrossRefGoogle Scholar
  30. [30]
    Sollom A.C., Kneebone I.I., Treatment of depression in people who have multiple sclerosis. Mult. Scler., 2007, Jun, 13(5), 632–635PubMedCrossRefGoogle Scholar
  31. [31]
    Blazer D.G., Depression in late life: review and commentary, J. Geront.: Med. Sci., 2003, 58A(3), 249–265CrossRefGoogle Scholar
  32. [32]
    Tandberg E., Larsen J.P., Aarsland D., Cummings J.L, The occurrence of depression in Parkinson’s disease. A community-based study, Arch. Neurol., 1996, 53(2), 175–179PubMedGoogle Scholar
  33. [33]
    Reijnders J. S., Ehrt U., Weber W. E., Aarsland D. and Leentjens A. F., A systematic review of prevalence studies of depression in Parkinson’s disease. Mov. Disord., 2008, 23(2), 183–189PubMedCrossRefGoogle Scholar
  34. [34]
    Massie M.J., Prevalence of depression in patients with cancer, J. Natl. Cancer Inst. Monogr., 2004, 32, 57–71PubMedCrossRefGoogle Scholar
  35. [35]
    Ciaramella A., Poli P., Assessment of depression among cancer patients: the role of pain, cancer type and treatment, Psychooncology, 2001, 10(2), 156–165PubMedCrossRefGoogle Scholar
  36. [36]
    Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J., The prevalence of comorbid depression in adults with diabetes. A meta-analysis, Diabetes Care, 2001, 24(6), 1069–1078PubMedCrossRefGoogle Scholar
  37. [37]
    Goldney R.D., Phillips P.J., Fisher L.J., Wilson D.H., Diabetes, depression, and quality of life: a population study, Diabetes Care, 2004, 27(5), 1066–1070PubMedCrossRefGoogle Scholar
  38. [38]
    Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., et al., Prevalence of depression in survivors of acute myocardial infarction, J. Gen. Int. Med., 2006, 21, 30–38CrossRefGoogle Scholar
  39. [39]
    Beal C., Stuifbergen A.K., Sands D.V., Brown A., Depression in multiple sclerosis: a longitudinal analysis, Arch. Psychiatr. Nurs., 2007, 21, 181–191PubMedCrossRefGoogle Scholar
  40. [40]
    Minden S.L., Mood disorders in multiple sclerosis: diagnosis and treatment, J. Neurovirol., 2000, 6(2), 160–167Google Scholar
  41. [41]
    Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis (1): early pension and temporary unemployment—a historical prospective cohort study, Mult. Scler., 2010, Jan, 16(1), 121–126PubMedCrossRefGoogle Scholar
  42. [42]
    Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis: clinical and demographic predictors — a historical prospective cohort study, Eur. J. Neurol., 2010, 17(11), 1346–1351PubMedGoogle Scholar
  43. [43]
    Julian L.J., Vella L., Vollmer T., Hadjimichael O., Mohr D.C., Employment in multiple sclerosis. Exiting and re-entering the work force, J. Neurol., 2008, 255(9), 1354–1360PubMedCrossRefGoogle Scholar
  44. [44]
    Busche K.D., Fisk J.D., Murray T.J., Metz L.M., Short term predictors of unemployment in multiple sclerosis patients. Can. J. Neurol. Sci., 2003, 30(2), 137–142PubMedGoogle Scholar
  45. [45]
    Putzki M., Fischer J., Gottwald K., Reifschneider G., Ries S., Siever A. et al., Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis, Eur. J. Neurol., 2009, 16(6), 713–720PubMedCrossRefGoogle Scholar
  46. [46]
    Jongen P.J., Sindic C., Carton H., Zwanikken C., Lemmens W., Borm G., Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon beta — 1a. J. Neurol., 2010, Apr, 257(4), 584–589PubMedCrossRefGoogle Scholar
  47. [47]
    Einarsson U., Gottberg K., Fredrikson S., von Koch L., Holmqvist L.W., Activities of daily living and social activities in people with multiple sclerosis in Stockholm County, Clin. Rehabil., 2006, 20(6), 543–551PubMedCrossRefGoogle Scholar
  48. [48]
    Buhse M., Assessment of caregiver burden in families of persons with multiple sclerosis, J. Neurosci. Nurs., 2008, 40(1), 25–31PubMedCrossRefGoogle Scholar
  49. [49]
    Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study, Mult. Scler., 2010, 16(7), 878–882PubMedCrossRefGoogle Scholar
  50. [50]
    MacLurg K., Reilly P., Hawkins S., Grav O., Evason E., Whittington D., A primary care-based needs assessment of people with multiple sclerosis, Br. J. Gen. Pract., 2005, 55(514), 378–383PubMedGoogle Scholar
  51. [51]
    Vazirinejad R., Lilley J., Ward C., A health profile of adults with multiple sclerosis living in the community, Mult. Scler., 2008, 14(8), 1099–1105PubMedCrossRefGoogle Scholar
  52. [52]
    Koopman W.J., Benbow C.L., Vandervoort M., Top 10 needs of people with multiple sclerosis and their significant others. J. Neurosci. Nurs., 2006, 38(5), 369–373PubMedCrossRefGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Rytis Leonavičius
    • 1
  • Virginija Adomaitienė
    • 1
  • Darius Leskauskas
    • 1
  1. 1.Department of Psychiatry of Medical Academy of Lithuanian University of Health SciencesKaunasRepublic of Lithuania

Personalised recommendations